J&J Focuses on Immunology with US$6.5 B Momenta Buyout

By Michelle Liu

Pharma Deals Review: Vol 2020 Issue 8 (Table of Contents)

Published: 24 Aug-2020

DOI: 10.3833/pdr.v2020.i8.2557     ISSN: 1756-7874

Section: Mergers & Acquisitions



In one of the largest M&A deals of 2020 so far, Johnson & Johnson (J&J) has agreed to acquire Momenta Pharmaceuticals for US$6...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details